ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
4 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
38K
|
17M
|
4
|
|
ASX - By Stock
|
CXO |
Aussie lithium on the docket for Germany
|
|
Fadda19
|
0 |
612 |
18 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
0
|
612
|
18
|
|
ASX - By Stock
|
CXO |
Re:
Is Core Lithium still overvalued?
|
|
Fadda19
|
77 |
41K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
77
|
41K
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Is Core Lithium still overvalued?
|
|
Fadda19
|
77 |
41K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
77
|
41K
|
2
|
|
ASX - By Stock
|
CXO |
Is Core Lithium still overvalued?
|
|
Fadda19
|
77 |
41K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
77
|
41K
|
2
|
|
ASX - By Stock
|
JAY |
Re:
This is a really dumb transaction - kill it
|
|
Fadda19
|
7 |
2.8K |
0 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
7
|
2.8K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Nuclear Medicine: From Concept to Clinic and Commercialization (CB chapter in Pr. Richard Baum tribute book)
|
|
Fadda19
|
17 |
8.6K |
1 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
17
|
8.6K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Nuclear Medicine: From Concept to Clinic and Commercialization (CB chapter in Pr. Richard Baum tribute book)
|
|
Fadda19
|
17 |
8.6K |
0 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
17
|
8.6K
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
1 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
38K
|
17M
|
1
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
0 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
38K
|
17M
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
2 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
38K
|
17M
|
2
|
|
ASX - By Stock
|
CXO Lithium |
Re:
How to screw over short-sellers
|
|
Fadda19
|
846 |
343K |
2 |
07/01/24 |
07/01/24 |
ASX - By Stock
|
846
|
343K
|
2
|
|
ASX - By Stock
|
CXO Lithium |
Re:
How to screw over short-sellers
|
|
Fadda19
|
846 |
343K |
0 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
846
|
343K
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Ann: Strategic Review Update
|
|
Fadda19
|
387 |
158K |
0 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
387
|
158K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Plans U.S. Registered Public Offering and Listing
|
|
Fadda19
|
45 |
18K |
1 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
45
|
18K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Fadda19
|
1.5K |
589K |
2 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
1.5K
|
589K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Fadda19
|
1.5K |
589K |
0 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
1.5K
|
589K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Fadda19
|
1.5K |
589K |
2 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
1.5K
|
589K
|
2
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
1 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
38K
|
17M
|
1
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Fadda19
|
1.5K |
589K |
2 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
1.5K
|
589K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Fadda19
|
1.5K |
589K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
1.5K
|
589K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Fadda19
|
1.0K |
470K |
6 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
1.0K
|
470K
|
6
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
0 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
38K
|
17M
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
1 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
38K
|
17M
|
1
|
|
ASX - By Stock
|
CXO |
Re:
Under $0.15
|
|
Fadda19
|
360 |
149K |
6 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
360
|
149K
|
6
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
2 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
38K
|
17M
|
2
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
1 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
38K
|
17M
|
1
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
1 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
38K
|
17M
|
1
|
|
ASX - By Stock
|
LTR |
Re:
ASX Today
|
|
Fadda19
|
40K |
18M |
1 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
40K
|
18M
|
1
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
1 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
38K
|
17M
|
1
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
2 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
38K
|
17M
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
Fadda19
|
138 |
52K |
1 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
138
|
52K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Closes SPP Raising $18.2 million
|
|
Fadda19
|
293 |
114K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
293
|
114K
|
0
|
|
ASX - By Stock
|
CXO |
Re:
CXO - Chart Thread
|
|
Fadda19
|
8.6K |
4.3M |
1 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
8.6K
|
4.3M
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Fadda19
|
507 |
167K |
9 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
507
|
167K
|
9
|
|
ASX - By Stock
|
CXO |
Re:
Ann: Completion of Share Purchase Plan
|
|
Fadda19
|
86 |
34K |
0 |
23/09/23 |
23/09/23 |
ASX - By Stock
|
86
|
34K
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
3 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
38K
|
17M
|
3
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
0 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
38K
|
17M
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
0 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
38K
|
17M
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
2 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
38K
|
17M
|
2
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
0 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
38K
|
17M
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
4 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
38K
|
17M
|
4
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Fadda19
|
1.5K |
589K |
1 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
1.5K
|
589K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Fadda19
|
1.5K |
589K |
0 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
1.5K
|
589K
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
1 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
38K
|
17M
|
1
|
|
ASX - By Stock
|
BGA |
Re:
Ann: Presentation - FY2023 Full Year Result
|
|
Fadda19
|
51 |
19K |
0 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
51
|
19K
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Ann: Development Projects Update - BP33 and Carlton
|
|
Fadda19
|
97 |
48K |
0 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
97
|
48K
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
0 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
38K
|
17M
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Fadda19
|
38K |
17M |
1 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
38K
|
17M
|
1
|
|